Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome
Condition:   Post-COVID-19 Syndrome Interventions:   Drug: Prednisolone 20 mg/ 5 mg;   Drug: Vitamin B compound (100mg B1, 50 mg B6, 500 µg B12);   Drug: Placebo for Vitamin B compound;   Drug: Placebo for Prednisolon Sponsors:   Wuerzburg University Hospital;   University Hospital Tuebingen;   University Hospital Schleswig-Holstein Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2022 Category: Research Source Type: clinical trials

The Treatment of Adrenal Crisis With Inhaled Prednisolone
Condition:   Adrenal Insufficiency Intervention:   Drug: Prednisolone Sponsor:   University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2022 Category: Research Source Type: clinical trials

Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome
Condition:   Post-COVID-19 Syndrome Interventions:   Drug: Prednisolone 20 mg/ 5 mg;   Drug: Vitamin B compound (100mg B1, 50 mg B6, 500 µg B12);   Drug: Placebo for Vitamin B compound;   Drug: Placebo for Prednisolon Sponsors:   Wuerzburg University Hospital;   University Hospital Tuebingen;   University Hospital Schleswig-Holstein Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2022 Category: Research Source Type: clinical trials

The Treatment of Adrenal Crisis With Inhaled Prednisolone
Condition:   Adrenal Insufficiency Intervention:   Drug: Prednisolone Sponsor:   University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2022 Category: Research Source Type: clinical trials

Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome
Condition:   Post-COVID-19 Syndrome Interventions:   Drug: Prednisolone 20 mg/ 5 mg;   Drug: Vitamin B compound (100mg B1, 50 mg B6, 500 µg B12);   Drug: Placebo for Vitamin B compound;   Drug: Placebo for Prednisolon Sponsors:   Wuerzburg University Hospital;   University Hospital Tuebingen;   University Hospital Schleswig-Holstein Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2022 Category: Research Source Type: clinical trials

The Treatment of Adrenal Crisis With Inhaled Prednisolone
Condition:   Adrenal Insufficiency Intervention:   Drug: Prednisolone Sponsor:   University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2022 Category: Research Source Type: clinical trials

Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome
Condition:   Post-COVID-19 Syndrome Interventions:   Drug: Prednisolone 20 mg/ 5 mg;   Drug: Vitamin B compound (100mg B1, 50 mg B6, 500 µg B12);   Drug: Placebo for Vitamin B compound;   Drug: Placebo for Prednisolon Sponsors:   Wuerzburg University Hospital;   University Hospital Tuebingen;   University Hospital Schleswig-Holstein Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2022 Category: Research Source Type: clinical trials

The Treatment of Adrenal Crisis With Inhaled Prednisolone
Condition:   Adrenal Insufficiency Intervention:   Drug: Prednisolone Sponsor:   University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2022 Category: Research Source Type: clinical trials

Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome
Condition:   Post-COVID-19 Syndrome Interventions:   Drug: Prednisolone 20 mg/ 5 mg;   Drug: Vitamin B compound (100mg B1, 50 mg B6, 500 µg B12);   Drug: Placebo for Vitamin B compound;   Drug: Placebo for Prednisolon Sponsors:   Wuerzburg University Hospital;   University Hospital Tuebingen;   University Hospital Schleswig-Holstein Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2022 Category: Research Source Type: clinical trials

The Treatment of Adrenal Crisis With Inhaled Prednisolone
Condition:   Adrenal Insufficiency Intervention:   Drug: Prednisolone Sponsor:   University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2022 Category: Research Source Type: clinical trials

Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome
Condition:   Post-COVID-19 Syndrome Interventions:   Drug: Prednisolone 20 mg/ 5 mg;   Drug: Vitamin B compound (100mg B1, 50 mg B6, 500 µg B12);   Drug: Placebo for Vitamin B compound;   Drug: Placebo for Prednisolon Sponsors:   Wuerzburg University Hospital;   University Hospital Tuebingen;   University Hospital Schleswig-Holstein Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2022 Category: Research Source Type: clinical trials

The Treatment of Adrenal Crisis With Inhaled Prednisolone
Condition:   Adrenal Insufficiency Intervention:   Drug: Prednisolone Sponsor:   University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2022 Category: Research Source Type: clinical trials

Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome
Condition:   Post-COVID-19 Syndrome Interventions:   Drug: Prednisolone 20 mg/ 5 mg;   Drug: Vitamin B compound (100mg B1, 50 mg B6, 500 µg B12);   Drug: Placebo for Vitamin B compound;   Drug: Placebo for Prednisolon Sponsors:   Wuerzburg University Hospital;   University Hospital Tuebingen;   University Hospital Schleswig-Holstein Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2022 Category: Research Source Type: clinical trials

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
Conditions:   Corneal Edema;   Corneal Defect;   Anterior Chamber Inflammation;   Ocular Pain;   Corneal Staining;   Visual Outcome;   CME - Cystoid Macular Edema Interventions:   Drug: Dextenza 0.4Mg Ophthalmic Insert;   Drug: Prednisolone Phosphate 1%/Moxifloxacin 0.5%/Bromfenac 0.075% compound Sponsor:   Nicole Fram M.D. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2022 Category: Research Source Type: clinical trials

An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis
Condition:   Hypersensitivity Pneumonitis Interventions:   Drug: Mycophenolate Mofetil plus prednisolone;   Drug: Prednisolone Sponsor:   Postgraduate Institute of Medical Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2022 Category: Research Source Type: clinical trials